Similar articles for PMID: 29858150

Year	Number of Results
1938	1
1944	1
1945	2
1963	1
1972	1
1976	1
1980	1
1992	3
1995	2
1996	2
1997	1
1998	4
2000	5
2001	1
2002	2
2003	1
2004	3
2005	2
2007	2
2008	4
2009	2
2010	5
2011	8
2012	6
2013	8
2014	4
2015	8
2016	9
2017	4
2018	11
2019	6
2020	3
2024	0

1

Mass chemoprophylaxis for control of outbreaks of meningococcal disease.

McNamara LA, MacNeil JR, Cohn AC, Stephens DS. McNamara LA, et al. Lancet Infect Dis. 2018 Sep;18(9):e272-e281. doi: 10.1016/S1473-3099(18)30124-5. Epub 2018 May 29. Lancet Infect Dis. 2018. PMID: 29858150 Free PMC article. Review.

2

Meningococcal disease in New Zealand.

Mills G, Bell A. Mills G, et al. N Z Med J. 2013 Apr 19;126(1373):10-1. N Z Med J. 2013. PMID: 23797072 No abstract available.

3

Evaluation of Mass Vaccination Clinics in Response to a Serogroup B Meningococcal Disease Outbreak at a Large, Public University-Oregon, 2015.

Fisher EA, Poissant T, Luedtke P, Leman R, Young C, Cieslak P. Fisher EA, et al. J Adolesc Health. 2018 Aug;63(2):151-156. doi: 10.1016/j.jadohealth.2018.03.018. J Adolesc Health. 2018. PMID: 30149923

4

Vaccination strategies for the prevention of meningococcal disease.

Vuocolo S, Balmer P, Gruber WC, Jansen KU, Anderson AS, Perez JL, York LJ. Vuocolo S, et al. Hum Vaccin Immunother. 2018 May 4;14(5):1203-1215. doi: 10.1080/21645515.2018.1451287. Epub 2018 Apr 13. Hum Vaccin Immunother. 2018. PMID: 29543535 Free PMC article. Review.

5

The Northland emergency meningococcal C vaccination programme.

Mills C, Penney L. Mills C, et al. N Z Med J. 2013 Apr 19;126(1373):30-9. N Z Med J. 2013. PMID: 23797074

6

From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak.

Caron F, du Châtelet IP, Leroy JP, Ruckly C, Blanchard M, Bohic N, Massy N, Morer I, Floret D, Delbos V, Hong E, Révillion M, Berthelot G, Lemée L, Deghmane AE, Bénichou J, Lévy-Bruhl D, Taha MK. Caron F, et al. Lancet Infect Dis. 2011 Jun;11(6):455-63. doi: 10.1016/S1473-3099(11)70027-5. Epub 2011 Apr 12. Lancet Infect Dis. 2011. PMID: 21489881

7

Experience implementing a university-based mass immunization program in response to a meningococcal B outbreak.

Capitano B, Dillon K, LeDuc A, Atkinson B, Burman C. Capitano B, et al. Hum Vaccin Immunother. 2019;15(3):717-724. doi: 10.1080/21645515.2018.1547606. Epub 2019 Jan 8. Hum Vaccin Immunother. 2019. PMID: 30462563 Free PMC article.

8

Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease.

La EM, Talbird SE, Kanadanian KV, Huang L, Fain J, Srivastava A. La EM, et al. Hum Vaccin Immunother. 2019;15(4):978-986. doi: 10.1080/21645515.2018.1556074. Epub 2019 Jan 16. Hum Vaccin Immunother. 2019. PMID: 30526279 Free PMC article.

9

Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP).

[No authors listed] [No authors listed] MMWR Recomm Rep. 1997 Feb 14;46(RR-5):13-21. MMWR Recomm Rep. 1997. PMID: 9048847 Free article.

10

Lessons from mass vaccination response to meningococcal B outbreaks at US universities.

Alderfer J, Isturiz RE, Srivastava A. Alderfer J, et al. Postgrad Med. 2020 Sep;132(7):614-623. doi: 10.1080/00325481.2020.1766265. Epub 2020 Jun 1. Postgrad Med. 2020. PMID: 32476532 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

109 results

Results by year